M. Bret Schneider

Corporate Officer/Principal presso Stanford University

Consumer Services

Health Technology

Profilo

M.
Bret Schneider was the founder of Cervel Neurotech, Inc. which was founded in 2008 where he held the title of Chief Medical Officer.
Currently, he is a Staff Scientist at Stanford University.
Dr. Schneider received his undergraduate degree from Washington University in St. Louis and his doctorate from Rush University.

Posizioni attive di M. Bret Schneider

Società	Posizione	Inizio
Stanford University	Corporate Officer/Principal	-

Tutte le posizioni attive di M. Bret Schneider

Precedenti posizioni note di M. Bret Schneider

Società	Posizione	Fine
Cervel Neurotech, Inc. Cervel Neurotech, Inc. Medical SpecialtiesHealth Technology Cervel Neurotech, Inc. develops and manufactures medical devices. It engages in the development of a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. The firm’s Cervel Multicoil Steerable TMS technology is a new approach to an established technology, repetitive transcranial magnetic stimulation, designed to produce better outcomes and a more comfortable treatment for patients. The company was founded in 2008 by M. Bret Schneider, David J. Mishelevich and Michael Joseph Partsch and is headquartered in Redwood City, CA.	Fondatore	-

Vedi nel dettaglio l'esperienza di M. Bret Schneider

Formazione di M. Bret Schneider

Washington University in St. Louis	Undergraduate Degree
Rush University	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di M. Bret Schneider

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Cervel Neurotech, Inc. Cervel Neurotech, Inc. Medical SpecialtiesHealth Technology Cervel Neurotech, Inc. develops and manufactures medical devices. It engages in the development of a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. The firm’s Cervel Multicoil Steerable TMS technology is a new approach to an established technology, repetitive transcranial magnetic stimulation, designed to produce better outcomes and a more comfortable treatment for patients. The company was founded in 2008 by M. Bret Schneider, David J. Mishelevich and Michael Joseph Partsch and is headquartered in Redwood City, CA.	Health Technology